As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
Chronic conditions with poor blood supply -- where the tissue needs ongoing support to rebuild vasculature -- fit this profile well
BPC-157, TB-500, MOTS-c, Semax, GLP-1 analogs & more strictly for controlled laboratory research
some individuals report sleep disturbances Foods and Substances to Avoid Around Dosing To optimize AOD-9604s effectiveness, avoid the following in the hour before and 30-60 minutes after administration: All foods (proteins, carbohydrates, fats trigger insulin response) Caloric beverages including juice, milk, sports drinks, protein shakes Artificial sweeteners (may trigger minor insulin response in some individuals) Coffee with cream or sugar (black coffee or tea without additives is acceptable) Acceptable During Dosing Window: Water, black coffee, unsweetened tea, electrolyte water (zero-calorie), and medications as prescribed
Key limitation: Most injectable GHK-Cu dosage protocols are extrapolated from topical human trials and animal studies
Boosts the immune system